• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on the significance of apo E in aherosclerosis

Research Project

Project/Area Number 05670407
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field 内科学一般
Research InstitutionAsahikawa Medical College

Principal Investigator

ETO Masaaki  Asahikawa Medical College Dept of Internal Med 2, Associate Professor, 医学部, 助教授 (90133818)

Project Period (FY) 1993 – 1994
Project Status Completed (Fiscal Year 1994)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1994: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1993: ¥1,600,000 (Direct Cost: ¥1,600,000)
Keywordsapo E / lipoprotein / remnant / triglycevide / Cholesterol / Macrophage / apo E allele / atherogenicity / 動脈硬化 / 脂質
Research Abstract

Apolipoprotein E is one of the protein constituents of VLDL,VLDL remnants and chylomicron remnants, which are atherogenic lipoproteins. TG-rich lipoproteins and their remnants are taken up by macrophages and cause the accumulation of cholestervl ester (CE), and then the formation of foam cells. apo E plays an important role in the above process as a ligand for the lipoprotein receptors. The significance of Apo E in the pathogenesis of atheroscler osis was examined in this study. The frequencies of apo E2 and E4 were significantly higher in patients with ischemic heart disease than in controls. Apo E2 is associated with type III hyperlipoproteinemia (HLP) and hypertriglyceridemia (type IV HLP) , whereas apo E4 is associated with hyper-cholesterolemia (type IIa and IIb HLP). Thus, apo E2 and E4 are atherogenic. We established a method for apo E genotyping by PCR-RFLP.ApoE2 increased plasma RLP (remnant-like particles) and caused postprandial lipemia, which is thought to be atherogenic. RLP and TG-rich lipoproteins derived from NIDDM and apo E2-associated hyperlipemia enhanced the CE synthesis as compared with those derived fromcontrols. It is concluded that apo E plays an important role in atherosclerosis.

Report

(3 results)
  • 1994 Annual Research Report   Final Research Report Summary
  • 1993 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Horite K, Eto M: "Apolipoprotein E2, renel failure and liped abnormalities in NIDDM" Atheropilerosis. 107. 203-211 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Eto M: "Plasme apo E rich HDL and apo E genetic polymorphism in normolipidemic subjects" J. Lipoprotein Res Soc. 13. 19-23 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Sai to M, Eto M: "Apolipoprotein E4 and Algheimer's disease" J. Lipoprotein Res Soc. 13. 26-31 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Horite K, Eto M: "Effects of apolipopnee E poly morplisr on plasme lipoproeei(a)levels" Artery. 20. 324-336 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Nakate H, Horite K, Eto M: "Alteration of lipoprotei(a)Concertretsa with glycemir control in NIDDM sabjects" Metabolism. 42. 1323-1326 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Chibc H, Eto M: "Lncreased plasma apolipoprotei E-rich HDL and its effect on serum HDL" Biochem Med Metabol Biology. 49. 79-89 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Eto M: "“Recent advances in triglyceride"Apolipoproteir E2 and hypertriglycericlewia" Churchill Living stone London, P187-199 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Horita K,Eto M,Makino I.: "Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin dependent diabetes mellitus." Atherosclerosis. 107. 203-211 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Eto M,Chiba H,Saito M,Nomura M,Okada M,Miyamoto Y,Abiko A,Matsumoto S,Morikawa A,Iwashima Y,Makino I: "Plasma apo E-rich HDL and apo E genetic polymorphism in normolipidemic subjects." J Lipoprotein Res Soc. 13. 19-23 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Saito M,Eto M,Sato M,Makino M,Nunomura A,Chiba S,Miyagishi T,Naoe J.Miyamoto T,Ota K: "Apolipoprotein E4 and Alzheimer's disease" J Lipoprotein Res Soc. 13. 26-31 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Iwashima Y,Abiko A,Seino S,Takeda J.Eto M et al: "Reduced levels of messenger ribonucleic acid for calcium channel, glucose transporter-2, and glucokinase are associated with alterations in insulin secretion in fasted rats" Endocrinology. 135. 1010-1017 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Eto M,Horita K,Morikawa A,Nakata H,Okada M,Satio M et al: "Increased frequency of apolipoprotein epsilon2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy" Clinical Genetics. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Eto M,Okada M,Horita K,Satio M,Kondo A,Nakajima K,Takahashi M,Iwashima Y,Morikawa A,Makino I.: "Apolipoprotein E2 and hypertriglyceridemia" Triglyceride and Atherosclerosis Yamamoto A,Nakamura H,Nakai T Chuichill Livengstone (Osaka Tokyo Edinburgh London). 187-199 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Horita K,Eto M et al: "Effects of apolipoprotein E polymorphism on plasma lipoprote in (a) levels" Artery. 20. 324-336 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Nakata H,Horita K,Eto M: "Alteration of lipoprotein (a) concentration with glycemic control in NIDDM patients." Metabolism. 42. 1323-1326 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Horita K. Eto M: "Apo lipoprotei E2, revel failure and lipid abnomalitris in NIDDM" Athero silerosis. 107. 203-211 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Eto M: "Plesme apoE rich HDL and apoE genitic poly-merphiom in normslipilemic Sabjicts" J. Lipoprotei Pes Soc. 13. 19-23 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Saito M, Eto M: "Apo lipoprotei E4 and Alyheimeis disease" J. Lipoprotei Pes Soc. 13. 26-31 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Eto M: "“Pecent Advanes in Troghycewde"Apo lipoprotei E2 and hypertrigly cerieuna" Churchill Livingstoue(London), 187-199 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 衛藤雅昭: "糖尿病患者由来TG-richリポ蛋白のatherogenicity" 糖尿病大血管障害. 2. 115-120 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] H.Chiba: "Increased plasma apolipoprotein E-rich high-density lipoprotein and its effect on serum high-density lipopro tein...." Biochemical Medicine and Metabolic Biology. 49. 79-89 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] H.Nakata: "Alteration of lipoprotein(a)Concentration with glycemic control u Nou-insulin-dependent diabetic subjects...." Metabolism. 42. 1323-1326 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] 衛藤雅昭: "糖尿病由来TG-richリポ蛋白によるマクロファージコレステリルエステル合成の促進" Therapeutic Research. 14. 505-508 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] K.Horita: "Effects of apolipoprotein E polymorphism on plasma lipoprotein(a)levels" Artery. 20(in press). (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] K.Horita: "Apolipoprotein E2,revel forlure and lipid abnormalities in nou-insulin-dependent diabetes mellitirs" Atheropclerosis. (in press).

    • Related Report
      1993 Annual Research Report
  • [Publications] M.Eto: "“Recent Advances in Triglycerides"Apoliprotein E2 and Hypertriglyceridemia" Churchill Livingstone KK (in press),

    • Related Report
      1993 Annual Research Report

URL: 

Published: 1993-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi